Vica-Cet Back Pain Relief tablets recalled for stability specification failure
Ultra Seal Corporation is recalling Vica-Cet Back Pain Relief tablets nationwide because certain lots failed stability testing and contain out-of-specification levels of Salicylic Acid, an aspirin-related compound.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as Class III. The recall is based on failed stability specifications with no reported illnesses, injuries, or harm. The hazard is documented but theoretical, supporting a Low severity classification.
Plain-English summary
Ultra Seal Corporation is recalling Vica-Cet Back Pain Relief tablets (Acetaminophen 250 mg / Aspirin 250 mg / Caffeine 65 mg) nationwide in the USA. The affected product consists of approximately 1,367,525 tablets packaged in 2-tablet packets as part of PO# 8967 for Tellus / The Provision First Aid Line.
The recall was initiated because stability testing revealed out-of-specification results for Salicylic Acid, an aspirin-related compound, in certain lots. The affected lots include: Lot #AK-9455 (expiration 22-Jan), Lot #AK-1109 (expiration 23-Mar), Lot #AK-1110 (expiration 23-Mar), and Lot #K-9821 (expiration 22-Sep).
Consumers who have purchased this product should stop using it. Consumers with questions or concerns should contact Ultra Seal Corporation or consult their healthcare provider.
The recalled product
- Product
- Vica-Cet BACK PAIN RELIEF (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets, 2 tablets/pk, packaged in 10,000 packets, PO# 8967, Mfg. for Tellus/The Provision First Aid Line (Shipping Label)
- Manufacturer
- Ultra Seal Corporation
- Category
- Drug — Pain Relief Tablets
- Hazard
- stability-failure
- out-of-specification-aspirin-metabolite
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot #: AK-9455
- exp. date 22-Jan
- AK-1109
- AK-1110
- exp. date 23-Mar
- K-9821
- exp. date 22-Sep
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27